BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16321545)

  • 1. A review on pro- and anti-angiogenic factors as targets of clinical intervention.
    Bouïs D; Kusumanto Y; Meijer C; Mulder NH; Hospers GA
    Pharmacol Res; 2006 Feb; 53(2):89-103. PubMed ID: 16321545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and hematological malignancies.
    Lim ST; Levine AM
    Hematology; 2005 Feb; 10(1):11-24. PubMed ID: 16019441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of new drugs in angiogenesis.
    Ziche M; Donnini S; Morbidelli L
    Curr Drug Targets; 2004 Jul; 5(5):485-93. PubMed ID: 15216914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiogenesis and its regulation].
    Iwaguchi T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):1-9. PubMed ID: 7678486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
    Hamsa TP; Kuttan G
    Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Targeting angiogenesis in oncology].
    Fayette J; Soria JC; Armand JP
    Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic targets for potential disorders.
    Bhadada SV; Goyal BR; Patel MM
    Fundam Clin Pharmacol; 2011 Feb; 25(1):29-47. PubMed ID: 20199582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis inhibitors. New anticancer strategy.
    Zgodziński W; Wallner G; Dabrowski A
    Pol J Pharmacol; 1999; 51(6):455-62. PubMed ID: 10817522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents.
    Goodwin AM
    Microvasc Res; 2007; 74(2-3):172-83. PubMed ID: 17631914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current protein-based anti-angiogenic therapeutics.
    Chakrabarti S; Barrow CJ; Kanwar RK; Ramana V; Kanwar JR
    Mini Rev Med Chem; 2014; 14(3):291-312. PubMed ID: 24552262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.
    Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M
    Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
    Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiotensin and its mediators. Their pathogenic and clinical significance in "angiogenic diseases"].
    Szekanecz Z; Bordán E; Szabó Z; Szegedi G
    Orv Hetil; 1998 Feb; 139(5):227-34. PubMed ID: 9489376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer drug targets: approaching angiogenesis.
    Keshet E; Ben-Sasson SA
    J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiogenesis: an update.
    Díaz-Flores L; Gutiérrez R; Varela H
    Histol Histopathol; 1994 Oct; 9(4):807-43. PubMed ID: 7534514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.